Tenaya Therapeutics Ownership 2024 | Who Owns Tenaya Therapeutics Now?
Institutional Ownership
4.28%
Insider Ownership
1.18%
Retail Ownership
94.54%
Institutional Holders
27.00
Tenaya Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COLUMN GROUP LLC | 11.61% | 40.88% | 9,400,290 | - | - | 29,140,899 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 9.41% | 0.31% | 7,622,347 | 1,867,297 | 32.45% | 23,629,276 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 8.31% | 1.60% | 6,732,971 | - | - | 20,872,210 | Jun 30, 2024 |
| BLACKROCK INC. | 5.03% | 0.00% | 4,074,056 | -626,941 | -13.34% | 12,629,573 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.34% | 0.00% | 3,513,724 | 167,202 | 5.00% | 10,893,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.91% | 0.00% | 3,164,266 | 301,350 | 10.53% | 9,809,225 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 3.18% | 1.26% | 2,576,200 | -277,800 | -9.73% | 7,986,220 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 2.87% | 0.68% | 2,325,000 | 75,000 | 3.33% | 7,207,500 | Jun 30, 2024 |
| VR ADVISER, LLC | 1.92% | 0.31% | 1,555,556 | - | - | 4,822,224 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.67% | 1.31% | 1,350,000 | 575,000 | 74.19% | 4,185,000 | Jun 30, 2024 |
| FMR LLC | 1.63% | 0.00% | 1,320,435 | -1,589,691 | -54.63% | 4,093,349 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.52% | 0.00% | 1,229,188 | 189,142 | 18.19% | 3,810,983 | Jun 30, 2024 |
| STATE STREET CORP | 1.30% | 0.00% | 1,049,392 | 80,095 | 8.26% | 3,253,115,000 | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | 1.25% | 0.40% | 1,015,705 | - | - | 3,148,686 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.23% | 0.01% | 1,000,000 | 600,000 | 150.00% | 3,100,000 | Jun 30, 2024 |
| ALPHABET INC. | 1.13% | 0.14% | 915,705 | - | - | 2,838,686 | Jun 30, 2024 |
| STEPSTONE GROUP LP | 0.57% | 0.29% | 462,163 | - | - | 1,432,705 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.49% | 0.00% | 394,004 | -3,657 | -0.92% | 1,221,412,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.44% | 0.01% | 357,500 | 167,500 | 88.16% | 1,108,250 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.35% | 0.00% | 280,661 | -94,441 | -25.18% | 870,049 | Jun 30, 2024 |
Tenaya Therapeutics's largest institutional shareholder is COLUMN GROUP LLC, holding 11.61% of the company's total share outstanding, currently valued at $29.14M. The top 10 institutional shareholders own together 52.25% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COLUMN GROUP LLC | 11.61% | 40.88% | 9,400,290 | - | - | 29,140,899 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 8.31% | 1.60% | 6,732,971 | - | - | 20,872,210 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.67% | 1.31% | 1,350,000 | 575,000 | 74.19% | 4,185,000 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 3.18% | 1.26% | 2,576,200 | -277,800 | -9.73% | 7,986,220 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 2.87% | 0.68% | 2,325,000 | 75,000 | 3.33% | 7,207,500 | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | 1.25% | 0.40% | 1,015,705 | - | - | 3,148,686 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 9.41% | 0.31% | 7,622,347 | 1,867,297 | 32.45% | 23,629,276 | Jun 30, 2024 |
| VR ADVISER, LLC | 1.92% | 0.31% | 1,555,556 | - | - | 4,822,224 | Jun 30, 2024 |
| STEPSTONE GROUP LP | 0.57% | 0.29% | 462,163 | - | - | 1,432,705 | Jun 30, 2024 |
| ALPHABET INC. | 1.13% | 0.14% | 915,705 | - | - | 2,838,686 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.04% | 0.07% | 30,600 | 30,600 | 100.00% | 94,860 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.22% | 0.04% | 182,062 | -41,989 | -18.74% | 564,000 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 0.27% | 0.03% | 222,222 | - | - | 688,888 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.08% | 0.03% | 63,838 | -725 | -1.12% | 197,898 | Jun 30, 2024 |
| ATTICUS WEALTH MANAGEMENT, LLC | 0.04% | 0.03% | 30,563 | -25,949 | -45.92% | 94,746 | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | 0.19% | 0.02% | 156,074 | -27,346 | -14.91% | 483,829 | Jun 30, 2024 |
| HIGHPOINT ADVISOR GROUP LLC | 0.09% | 0.02% | 68,890 | -1,500 | -2.13% | 256,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.01% | 168,000 | -25,000 | -12.95% | 520,800 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.01% | 32,603 | 1,727 | 5.59% | 101,069 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.44% | 0.01% | 357,500 | 167,500 | 88.16% | 1,108,250 | Jun 30, 2024 |
The largest Tenaya Therapeutics shareholder by % of total assets is COLUMN GROUP LLC. The company owns 9.40M shares of Tenaya Therapeutics (TNYA), representing 40.88% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.41% | 0.31% | 7,622,347 | 1,867,297 | 32.45% | 23,629,276 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.23% | 0.01% | 1,000,000 | 600,000 | 150.00% | 3,100,000 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.67% | 1.31% | 1,350,000 | 575,000 | 74.19% | 4,185,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.91% | 0.00% | 3,164,266 | 301,350 | 10.53% | 9,809,225 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.52% | 0.00% | 1,229,188 | 189,142 | 18.19% | 3,810,983 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.44% | 0.01% | 357,500 | 167,500 | 88.16% | 1,108,250 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.34% | 0.00% | 3,513,724 | 167,202 | 5.00% | 10,893,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.27% | 0.00% | 219,983 | 137,871 | 167.91% | 681,948 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.19% | 0.00% | 157,460 | 92,960 | 144.12% | 488,126 | Jun 30, 2024 |
| STATE STREET CORP | 1.30% | 0.00% | 1,049,392 | 80,095 | 8.26% | 3,253,115,000 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 2.87% | 0.68% | 2,325,000 | 75,000 | 3.33% | 7,207,500 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.09% | 0.00% | 74,715 | 74,715 | 100.00% | 232,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.15% | 0.00% | 120,704 | 55,816 | 86.02% | 374,182 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.07% | 0.00% | 52,744 | 52,744 | 100.00% | 163,506 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.13% | 0.00% | 101,717 | 45,717 | 81.64% | 315,323 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.04% | 0.07% | 30,600 | 30,600 | 100.00% | 94,860 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.13% | 0.00% | 102,026 | 30,446 | 42.53% | 316,281 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 29,675 | 29,675 | 100.00% | 91,993 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.29% | 0.00% | 237,597 | 26,103 | 12.34% | 736,551 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.19% | 0.00% | 152,588 | 24,468 | 19.10% | 473,023 | Jun 30, 2024 |
As of Jun 30 2024, Tenaya Therapeutics's largest institutional buyer is RA CAPITAL MANAGEMENT, L.P.. The company purchased 1.87M stocks of TNYA, valued at $23.63M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 1.63% | 0.00% | 1,320,435 | -1,589,691 | -54.63% | 4,093,349 | Jun 30, 2024 |
| BLACKROCK INC. | 5.03% | 0.00% | 4,074,056 | -626,941 | -13.34% | 12,629,573 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 3.18% | 1.26% | 2,576,200 | -277,800 | -9.73% | 7,986,220 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.01% | 0.00% | 11,862 | -167,270 | -93.38% | 36,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.22% | - | 177,723 | -138,166 | -43.74% | 550,941 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -127,232 | -100.00% | - | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -122,222 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.16% | - | 125,686 | -100,183 | -44.35% | 389,625 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.35% | 0.00% | 280,661 | -94,441 | -25.18% | 870,049 | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | - | 16,845 | -93,331 | -84.71% | 52,220 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.14% | 0.00% | 110,799 | -57,766 | -34.27% | 343,477 | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -43,300 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.22% | 0.04% | 182,062 | -41,989 | -18.74% | 564,000 | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | 0.19% | 0.02% | 156,074 | -27,346 | -14.91% | 483,829 | Jun 30, 2024 |
| ATTICUS WEALTH MANAGEMENT, LLC | 0.04% | 0.03% | 30,563 | -25,949 | -45.92% | 94,746 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.01% | 168,000 | -25,000 | -12.95% | 520,800 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -22,894 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -20,371 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -18,267 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -16,194 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Tenaya Therapeutics's biggest institutional seller is FMR LLC. The company sold -1.59M shares of TNYA, valued at $4.09M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.09% | 0.00% | 74,715 | 74,715 | 100.00% | 232,000 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.07% | 0.00% | 52,744 | 52,744 | 100.00% | 163,506 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 29,675 | 29,675 | 100.00% | 91,993 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.03% | 0.00% | 23,837 | 23,837 | 100.00% | 74,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 22,778 | 22,778 | 100.00% | 70,612 | Jun 30, 2024 |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 0.03% | 0.00% | 21,844 | 21,844 | 100.00% | 68,000 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.00% | 21,749 | 21,749 | 100.00% | 67,422 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.02% | 0.00% | 16,227 | 16,227 | 100.00% | 50,304 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.02% | 0.00% | 13,720 | 13,720 | 100.00% | 43,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.01% | 0.00% | 11,513 | 11,513 | 100.00% | 35,690 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.01% | 3,300 | 3,300 | 100.00% | 10,230 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,617 | 1,617 | 100.00% | 5,012 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 612 | 612 | 100.00% | 1,799 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | - | 105 | 105 | 100.00% | 326 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 65 | 65 | 100.00% | 202 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | 38 | 38 | 100.00% | 118 | Jun 30, 2024 |
Tenaya Therapeutics's largest new institutional shareholder by number of shares is EXODUSPOINT CAPITAL MANAGEMENT, LP, purchased 74.72K shares, valued at $232.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -127,232 | -100.00% | - | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -122,222 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -43,300 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -22,894 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -20,371 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -18,267 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -16,194 | -100.00% | - | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | - | - | - | -15,251 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -11,315 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -3,354 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,776 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
Tenaya Therapeutics's largest sold out institutional shareholder by shares sold is QUBE RESEARCH & TECHNOLOGIES LTD, sold -0.13M shares, valued at -, as of undefined.
Tenaya Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Tema ETF Trust | 3.24% | 144,698 | 96,805 | 202.13% | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.51% | 2,577,095 | 156,291 | 6.46% | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.32% | 1,069,162 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.23% | 58,697 | 33,195 | 130.17% | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.22% | 580,851 | 415,122 | 250.48% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.11% | 883,580 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.08% | 181,900 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 30,884 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 383,678 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.04% | 2,825,413 | 1,348,034 | 91.24% | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.04% | 59,906 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.03% | 117,263 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 79,481 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 142,688 | - | - | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.01% | 40,367 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 1,083,710 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,815 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 56,600 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,498,166 | -256,577 | -9.31% | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 62,288 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 131,374 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 80,377 | 620 | 0.78% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 119,532 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 32,623 | 31,547 | 2931.88% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 47,939 | 46,516 | 3268.87% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 436,200 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 410,362 | 46,392 | 12.75% | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 470,771 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 42,431 | 16,676 | 64.75% | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 30,222 | 14,133 | 87.84% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 285 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,317 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 3,577 | - | - | Mar 28, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 28,416 | - | - | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 10,267 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,431 | -421 | -14.76% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 14,767 | -3,618 | -19.68% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 46,194 | 5,072 | 12.33% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,087 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 12,178 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 38,320 | 15,331 | 66.69% | Jan 31, 2024 |
| BlackRock ETF Trust | 0.00% | 245 | 9 | 3.81% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 15,800 | -4,900 | -23.67% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 17,634 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 25,130 | -1,954 | -7.21% | Mar 28, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 141,753 | 118,990 | 522.73% | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 843,991 | 412,915 | 95.79% | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 12,792 | - | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 1,697,395 | -39,467 | -2.27% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 200,474 | 23,456 | 13.25% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 417 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 107,936 | -27,297 | -20.19% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 17,828 | 192 | 1.09% | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 1,265 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,500 | -400 | -21.05% | Mar 28, 2024 |
| FIDELITY SUMMER STREET TRUST | 0.00% | 18,312 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 207 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 6,660 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 132,365 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,744 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 17,368 | -28,215 | -61.90% | Jan 31, 2024 |
| ProFunds | 0.00% | 361 | -29 | -7.44% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 6,806 | 891 | 15.06% | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 27,231 | -90,552 | -76.88% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 6,026 | 1,104 | 22.43% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 153 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 27 | - | - | Dec 31, 2023 |
| Brinker Capital Destinations Trust | 0.00% | 1,104 | 1,104 | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 16,413 | 418 | 2.61% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 58,969 | 21,035 | 55.45% | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 38,100 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 5,263 | 56 | 1.08% | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 1,500 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,223 | - | - | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 3,895 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 34,579 | -759 | -2.15% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 8,468 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 16,108 | -17,309 | -51.80% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 19,169 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 84 | - | - | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 21,031 | -12,800 | -37.84% | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 5,455 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 6,080 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 3,000 | - | - | Feb 29, 2024 |
Tenaya Therapeutics's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 144.70K shares, compromising 3.24% of its total assets.
Tenaya Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 27 | -70.00% |
| 31 Mar, 24 | 90 | 20.00% |
| 31 Dec, 23 | 75 | -5.06% |
| 30 Sep, 23 | 79 | -4.82% |
| 30 Jun, 23 | 83 | 22.06% |
| 31 Mar, 23 | 68 | -1.45% |
| 31 Dec, 22 | 69 | - |
| 30 Sep, 22 | 69 | 40.82% |
| 30 Jun, 22 | 49 | -2.00% |
| 31 Mar, 22 | 50 | 8.70% |
| 31 Dec, 21 | 46 | -2.13% |
| 30 Sep, 21 | 47 | - |
As of 30 Jun 24, 27 institutions are holding Tenaya Therapeutics's shares, representing a decrease of -70.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 3,463,095 | -93.80% |
| 31 Mar, 24 | 55,822,180 | 19.53% |
| 31 Dec, 23 | 46,699,776 | -6.12% |
| 30 Sep, 23 | 49,741,546 | 4.38% |
| 30 Jun, 23 | 47,652,027 | 5.83% |
| 31 Mar, 23 | 45,028,302 | -4.44% |
| 31 Dec, 22 | 47,120,530 | 33.71% |
| 30 Sep, 22 | 35,241,221 | -4.92% |
| 30 Jun, 22 | 37,063,042 | -0.77% |
| 31 Mar, 22 | 37,349,308 | 5.64% |
| 31 Dec, 21 | 35,354,563 | 4.44% |
| 30 Sep, 21 | 33,851,067 | - |
Tenaya Therapeutics (TNYA) has 3.46M shares outstanding as of 30 Jun 24, down -93.80% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 4.28% | 0.07% |
| 31 Mar, 24 | 75.65% | 1.90% |
| 31 Dec, 23 | 63.17% | 1.38% |
| 30 Sep, 23 | 67.77% | 1.59% |
| 30 Jun, 23 | 65.19% | 1.72% |
| 31 Mar, 23 | 61.60% | 0.56% |
| 31 Dec, 22 | 105.12% | 1.45% |
| 30 Sep, 22 | 85.21% | 1.06% |
| 30 Jun, 22 | 89.74% | 1.10% |
| 31 Mar, 22 | 90.50% | 1.23% |
| 31 Dec, 21 | 85.70% | 0.54% |
| 30 Sep, 21 | 125.86% | - |
As of 30 Jun 24, Tenaya Therapeutics is held by 4.28% institutional shareholders, representing a 0.07% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 19 | -60.42% |
| 31 Mar, 24 | 48 | 33.33% |
| 31 Dec, 23 | 36 | -18.18% |
| 30 Sep, 23 | 44 | -21.43% |
| 30 Jun, 23 | 56 | 40.00% |
| 31 Mar, 23 | 40 | - |
| 31 Dec, 22 | 40 | -9.09% |
| 30 Sep, 22 | 44 | 175.00% |
| 30 Jun, 22 | 16 | -44.83% |
| 31 Mar, 22 | 29 | - |
| 31 Dec, 21 | 29 | -38.30% |
| 30 Sep, 21 | 47 | - |
19 institutional shareholders have increased their position in TNYA stock as of 30 Jun 24 compared to 48 in the previous quarter (a -60.42% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 5 | -80.77% |
| 31 Mar, 24 | 26 | 4.00% |
| 31 Dec, 23 | 25 | 92.31% |
| 30 Sep, 23 | 13 | 18.18% |
| 30 Jun, 23 | 11 | -8.33% |
| 31 Mar, 23 | 12 | -7.69% |
| 31 Dec, 22 | 13 | 30.00% |
| 30 Sep, 22 | 10 | -52.38% |
| 30 Jun, 22 | 21 | 133.33% |
| 31 Mar, 22 | 9 | 350.00% |
| 31 Dec, 21 | 2 | - |
| 30 Sep, 21 | - | - |
5 institutional shareholders have reduced their position in TNYA stock as of 30 Jun 24 compared to 26 in the previous quarter (a -80.77% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 27 | -70.00% | 3,463,095 | -93.80% | 4.28% | 0.07% | 19 | -60.42% | 5 | -80.77% |
| 31 Mar, 24 | 90 | 20.00% | 55,822,180 | 19.53% | 75.65% | 1.90% | 48 | 33.33% | 26 | 4.00% |
| 31 Dec, 23 | 75 | -5.06% | 46,699,776 | -6.12% | 63.17% | 1.38% | 36 | -18.18% | 25 | 92.31% |
| 30 Sep, 23 | 79 | -4.82% | 49,741,546 | 4.38% | 67.77% | 1.59% | 44 | -21.43% | 13 | 18.18% |
| 30 Jun, 23 | 83 | 22.06% | 47,652,027 | 5.83% | 65.19% | 1.72% | 56 | 40.00% | 11 | -8.33% |
| 31 Mar, 23 | 68 | -1.45% | 45,028,302 | -4.44% | 61.60% | 0.56% | 40 | - | 12 | -7.69% |
| 31 Dec, 22 | 69 | - | 47,120,530 | 33.71% | 105.12% | 1.45% | 40 | -9.09% | 13 | 30.00% |
| 30 Sep, 22 | 69 | 40.82% | 35,241,221 | -4.92% | 85.21% | 1.06% | 44 | 175.00% | 10 | -52.38% |
| 30 Jun, 22 | 49 | -2.00% | 37,063,042 | -0.77% | 89.74% | 1.10% | 16 | -44.83% | 21 | 133.33% |
| 31 Mar, 22 | 50 | 8.70% | 37,349,308 | 5.64% | 90.50% | 1.23% | 29 | - | 9 | 350.00% |
| 31 Dec, 21 | 46 | -2.13% | 35,354,563 | 4.44% | 85.70% | 0.54% | 29 | -38.30% | 2 | - |
| 30 Sep, 21 | 47 | - | 33,851,067 | - | 125.86% | - | 47 | - | - | - |
Tenaya Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Tenaya Therapeutics's stock was made by Tingley Whittemore on Aug 16 2024, selling 5,803 shares at $2.89 per share (valued at $16.80K). The last insider buy of TNYA was made by COLUMN GROUP III GP, LP on Feb 14 2024, buying 2,222,222 shares at $4.50 per share (worth $10.00M).
Tenaya Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 4 | - |
| Q1 2024 | 10 | 7 | 142.86% |
| Q3 2023 | - | 5 | - |
| Q2 2023 | 9 | - | - |
| Q1 2023 | 21 | - | - |
| Q4 2022 | 7 | - | - |
| Q3 2022 | 1 | - | - |
| Q2 2022 | 12 | 1 | 1200.00% |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 2 | - | - |
| Q3 2021 | 11 | 33 | 33.33% |
0 total buy trades, and 4 total sell trades (buy/sell ratio of 0.00%) were made by Tenaya Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 4 | - |
| Q1 2024 | 2 | 7 | 28.57% |
| Q3 2023 | - | 5 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | 10 | - | - |
| Q4 2022 | 6 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Tenaya Therapeutics's stocks.
Tenaya Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| AKRO | Akero Therapeutics, Inc. |
| GOSS | Gossamer Bio, Inc. |
| RANI | Rani Therapeutics Holdings, Inc. |
| BMEA | Biomea Fusion, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| CRVS | Corvus Pharmaceuticals, Inc. |
| ALXO | ALX Oncology Holdings Inc. |
| OCUL | Ocular Therapeutix, Inc. |
| IGMS | IGM Biosciences, Inc. |
| INZY | Inozyme Pharma, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| EYEN | Eyenovia, Inc. |
| VINC | Vincerx Pharma, Inc. |
| DRTS | Alpha Tau Medical Ltd. |
| FIXX | Q32 Bio Inc. |
| BCYC | Bicycle Therapeutics plc |
TNYA Ownership FAQ
Who Owns Tenaya Therapeutics?
Tenaya Therapeutics is owned by institutional shareholders (4.28%), insiders (1.18%), and public (94.54%). The largest institutional shareholder of Tenaya Therapeutics is COLUMN GROUP LLC (11.61% of total shares) and the top mutual fund owner is Tema ETF Trust (3.24% of total shares).
Who are the major institutional shareholders of Tenaya Therapeutics?
Tenaya Therapeutics's major institutional shareholders are COLUMN GROUP LLC, RA CAPITAL MANAGEMENT, L.P., CASDIN CAPITAL, LLC, BLACKROCK INC., and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 38.70% of the company's share outstanding.
How many Tenaya Therapeutics shareholders are there?
As of Jun 2024, there are 27 institutional shareholders of Tenaya Therapeutics.
What percentage of Tenaya Therapeutics is owned by COLUMN GROUP LLC?
COLUMN GROUP LLC owns 9.4M shares of Tenaya Therapeutics, representing 11.61% of the company's total shares outstanding, valued at $29.14M (as of Jun 2024).
What percentage of Tenaya Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
As of Jun 2024, RA CAPITAL MANAGEMENT, L.P holds 7.62M shares of Tenaya Therapeutics (TNYA), compromising 9.41% of the company, valued at $23.63M.
What percentage of Tenaya Therapeutics is owned by CASDIN CAPITAL, LLC?
CASDIN CAPITAL, LLC is the third largest holder of Tenaya Therapeutics. The company owns 6.73M of the company's shares outstanding (worth $20.87M).